With over 20 years of pharmaceutical experience covering sales and commercial roles, Chris is currently responsible for managing the Icon Group procurement, including international sites.
Chris also oversees pricing strategy and government reforms to ensure the oncology ecosystem remains viable as the market changes. Previously, Chris managed operations at one of Slade Health’s TGA-licensed facilities.